Loading...

Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer

Abiraterone acetate is the first second-line hormonal agent proven to improve survival in metastatic castration-resistant prostate cancer. It selectively inhibits cytochrome P450 17 (CYP17) α-hydroxylase and cytochrome(17,20) (C(17,20))-lyase, which are enzymes critical for androgen synthesis. Abira...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Harshman, Lauren C., Taplin, Mary-Ellen
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3778906/
https://ncbi.nlm.nih.gov/pubmed/23979793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0050-3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!